U.S. Commercialization for Israel's Biomedical Products
The FL-IBI provides a very well-suited marketing and distribution vehicle for the U.S. commercialization of Israel?omedical devices and products.* The main benefits to the Israeli biomedical companies seeking U.S. distribution relates to M-EDG??Equity-based Business Model?an>, which provides significant equity/ownership rather than simply a royalty under a conventional licensing agreement.
The main benefits to the Israeli companies and their owners are:
to read a list of
incredible scientific and technology breakthroughs
is produced by Stand
With Us, and provides an excellent introduction and historical
perspective to many of the issues facing Israel and the world.